advertisement
Hashimoto M 19
Showing records 1 to 19 |
Display all abstracts from Hashimoto M75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeAizawa N
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaNitta K; Wajima R
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeKunikata H; Shiga Y
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaTachibana G
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeTsuda S
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaInoue S; Ohigashi T
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeYokoyama Y
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaOtsuka N
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeOmodaka K
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaKurashima H
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeYasui T
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaSanto K
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeKato K
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaHashimoto M
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeKurashima H; Miyamoto E
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaShibahara H
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeHashimoto M
PLoS ONE 2017; 12: e0188692
75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension GlaucomaHirukawa M; Sugiyama K
Scientific reports 2017; 7: 15048
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eyeNakazawa T
PLoS ONE 2017; 12: e0188692
Issue 19-2
Change Issue
advertisement